Urothelial Bladder Carcinoma | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with Urothelial Bladder Carcinoma

Featuring perspectives from Dr Jonathan Rosenberg, including the following topics: Introduction: Antibody-drug conjugates in the news (0:00) Case: A man in his early 70s with metastatic urothelial bladder cancer (mUBC) — Helen H Moon, MD (9:19) Case: A woman in her mid 80s with non-muscle-invasive UBC with an FGFR2 tumor mutation — Henna Malik, MD (15:14) Case: A woman in her early 70s with mUBC, PD-L1 30% — Sulfi Ibrahim, MD (27:46) Case: A woman in her mid-70s with BCG-refractory non-muscle-invasive bladder carcinoma in situ — Jason Hafron, MD (48:23) Case: A man in his early 60s with BCG-refractory non-muscle-invasive UBC — Dr Ibrahim (52:49) CME information and select publications